About 9 results found for searched term "65-46-3" (0.057 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5497 | Cefpiramide sodium | Antibiotic |
| SM-1652; Wy-44635 | ||
| Cefpiramide sodium (SM-1652; Wy-44635) is a new Pseudomonas-active cephalosporin with a broad spectrum of antibacterial activity. | ||
| M5545 | Cytidine | DNA/RNA Synthesis |
| Cytosine β-D-riboside; Cytosine-1-β-D-ribofuranoside | ||
| Cytidine is a nucleoside molecule that is formed when cytosine is attached to a ribose ring, cytidine is a component of RNA. | ||
| M7460 | URB 602 | Antibiotic |
| URB602 is a selective monacylglycerol lipase (MGL) inhibitor with IC50 of 28±4 μM. | ||
| M14208 | Endovion | Chloride Channel |
| NS3728 | ||
| Endovion (NS3728) is a pharmacological anion channel inhibitor (like chloride channel) and the specific VRAC/VSOAC blocker. Endovion (NS3728) is also an Anoctamin-1 (ANO 1) channel inhibitor. | ||
| M24995 | Melrilimab | IL Receptor/Related |
| GSK 3772847; CNTO-7160 | ||
| Melrilimab (GSK 3772847) is an IgG2-kappa anti-IL1RL1/ST2/IL33R/DER4/FIT-1 monoclonal antibody. Melrilimab can be used for the research of asthma. | ||
| M25134 | Lorigerlimab | PD-1/PD-L1 |
| MGD019 | ||
| Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting antibody (DART). Lorigerlimab can block PD-1 and CTLA-4, and improves T-cell responses. Lorigerlimab can be used for research of metastatic castration-resistant prostate cancer (mCRPC). | ||
| M29531 | OICR12694 | Bcl-2 |
| JNJ-65234637 | ||
| OICR12694 (JNJ-65234637) is an orally active inhibitor of B cell lymphoma 6 (BCL6). | ||
| M29532 | OICR12694 TFA | Bcl-2 |
| JNJ-65234637 TFA | ||
| OICR12694 (JNJ-65234637) TFA is an orally active inhibitor of B cell lymphoma 6 (BCL6). | ||
| M50479 | 293P-1 | Others |
| 293P-1 is a peptide with tissue-specific homing properties. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
